These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10523971)

  • 1. [Role of fibrinolytic enzymes in corneal ulceration].
    Beznos OV; Chesnokova NB
    Vestn Oftalmol; 1999; 115(4):42-4. PubMed ID: 10523971
    [No Abstract]   [Full Text] [Related]  

  • 2. Latent and active plasminogen activator in corneal ulceration.
    Wang HM; Berman M; Law M
    Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):511-24. PubMed ID: 2984139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fibrinolytic enzyme system and its role in the etiology of thromboembolic disease.
    Wiman B; Hamsten A
    Semin Thromb Hemost; 1990 Jul; 16(3):207-16. PubMed ID: 2146744
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasminogen activator activity in tears after excimer laser photorefractive keratectomy.
    Csutak A; Tözsér J; Békési L; Hassan Z; Berta A; Silver DM
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3743-7. PubMed ID: 11053271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of matrix metalloproteinase activity in equine tear fluid during corneal healing in 10 horses with ulcerative keratitis.
    Ollivier FJ; Brooks DE; Van Setten GB; Schultz GS; Gelatt KN; Stevens GR; Blalock TD; Andrew SE; Komaromy AM; Lassaline ME; Kallberg ME; Cutler TJ
    Vet Ophthalmol; 2004; 7(6):397-405. PubMed ID: 15511281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and biochemical mechanisms involved in the degradation and healing of the cornea. The polymorphonuclear leukocyte and tear fluid serum antiproteases in human melting central corneal ulcers.
    Prause JU
    Acta Ophthalmol Suppl; 1984; 168():1-40. PubMed ID: 6207703
    [No Abstract]   [Full Text] [Related]  

  • 7. [The fibrinolytic system in the postoperative phase and its importance in normal and disturbed wound healing].
    Woziwodzki G
    Zentralbl Chir; 1967; 92(26a Pt 1):1086-90. PubMed ID: 4232849
    [No Abstract]   [Full Text] [Related]  

  • 8. Proteinases of the cornea and preocular tear film.
    Ollivier FJ; Gilger BC; Barrie KP; Kallberg ME; Plummer CE; O'Reilly S; Gelatt KN; Brooks DE
    Vet Ophthalmol; 2007; 10(4):199-206. PubMed ID: 17565550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of plasminogen activator activities in normal and pathological human tears. The significance of tear plasminogen activators in the inflammatory and traumatic lesions of the cornea and the conjunctiva.
    Berta A; Tözsér J; Holly FJ
    Acta Ophthalmol (Copenh); 1990 Oct; 68(5):508-14. PubMed ID: 2275342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with plasmin inhibitors.
    Tervo T; van Setten GB; Tervo K; Tarkkanen A
    Acta Ophthalmol Suppl (1985); 1992; (202):47-53. PubMed ID: 1322011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fibrinolytic system in the cornea: A key regulator of corneal wound healing and biological defense.
    Sugioka K; Fukuda K; Nishida T; Kusaka S
    Exp Eye Res; 2021 Mar; 204():108459. PubMed ID: 33493476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological role of fibrinolysis.
    Davidson JF; Walker ID
    J Clin Pathol Suppl (R Coll Pathol); 1980; 14():1-4. PubMed ID: 6448868
    [No Abstract]   [Full Text] [Related]  

  • 13. Corneal ulceration and the serum antiproteases. I. Alpha 1-antitrypsin.
    Berman MB; Barber JC; Talamo RC; Langley CE
    Invest Ophthalmol; 1973 Oct; 12(10):759-70. PubMed ID: 4361492
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinolysis and liver regeneration].
    Seki T; Uno S; Ariga T
    Seikagaku; 1999 May; 71(5):350-3. PubMed ID: 10391987
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasminogen activator/plasmin system: a major player in wound healing?
    Li WY; Chong SS; Huang EY; Tuan TL
    Wound Repair Regen; 2003; 11(4):239-47. PubMed ID: 12846910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic role of the plasminogen-plasmin system: thrombolysis, bleeding, and beyond.
    Kwaan HC; Mazar AP
    Semin Thromb Hemost; 2013 Jun; 39(4):327-8. PubMed ID: 23712353
    [No Abstract]   [Full Text] [Related]  

  • 17. Activity of coagulation and fibrinolytic system components in the vein thrombus.
    Guzowski A; Gacko M; Worowska A; Kowalewski R; Ostapowicz R; Ploński A
    Adv Med Sci; 2006; 51():205-7. PubMed ID: 17357310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of tears lysozyme in some eye diseases.
    el-Gammal MY; Mostafa MS
    Bull Ophthalmol Soc Egypt; 1971; 64(68):285-97. PubMed ID: 5154725
    [No Abstract]   [Full Text] [Related]  

  • 20. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.